Thomas Diacovo, MD
Schedule an Appointment
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Credentials & Experience
Board Certifications
- Neonatal-Perinatal Medicine
Clinical Expertise
- Pediatric Critical Care
Specialties
Education & Training
- McGill University Faculty of Medicine
- Residency: Baylor Affiliated Hospitals
- Fellowship: Children's Hospital of Boston
About Thomas Diacovo
Email: td2142@cumc.columbia.edu
Academic Titles
- Associate Professor of Pediatrics at CUMC
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Research
Clinical Trials
NCT02564718 7-day Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children From Birth to Less Than 6 Months With Arterial or Venous Thrombosis (Einstein Jr)
NCT02765633 A Prospective, Open-Label, Single-Arm, Single-Center Study To Assess The Pharmacokinetics/Pharmacodynamics (PK/PD) And Safety Of Different Cangrelor Doses In Neonatal Subjects At Risk Of Thrombosis
Grants
NEONATAL AND PEDIATRIC PLATELET FUNCTION AND PHARMACOLOGY (Federal Gov)
Jul 1 2015 - Jun 30 2020
NEONATAL AND PEDIATRIC PLATELET FUNCTION AND PHARMACOLOGY (Federal Gov)
Jul 1 2015 - Jun 30 2020
ANALYSIS OF PLATELET FUNCTION AND MICRORNA-MRNA PROFILES IN NEONATAL CARDIAC PATIENTS (Private)
Jul 1 2016 - Jun 30 2019
PRECLINICAL EVALUATION OF THE P2Y12 INHIBITOR CANGRELOR FOR USE IN PEDIATRIC PATIENTS (Private)
Jun 28 2013 - Jun 27 2018
ASSESSMENTOF BIOREACTOR-DERIVED HUMAN PLATELET QUALITY, STORAGE PROFILE, SAFETY, AND FUNCTION (Federal Gov)
Apr 1 2016 - Mar 31 2018
DEVELOPING A BIOLOGICALLY MATCHED TRANSFUSION PRODUCT FOR CRITICALLY ILL NEONATES: CORD BLOOD PLATELETS (Private)
Jul 1 2017 - Dec 31 2017
TARGETING NON-CLASSICAL ONCOGENES AS THERAPY FOR T-ALL (Federal Gov)
Aug 1 2012 - May 31 2017
TARGETING NON-CLASSICAL ONCOGENES AS THERAPY FOR T-ALL (Federal Gov)
Aug 1 2012 - May 31 2017
TARGETING NON-CLASSICAL ONCOGENES AS THERAPY FOR T-ALL (Federal Gov)
Aug 1 2012 - May 31 2017
PRECLINICAL AND CLINICAL EVALUATION OF PROTEIN KINASE INHIBITORS ON PLATELET FUNCTION (Private)
Sep 1 2014 - Aug 31 2015
GPIB ALPHA-VWF-A1 BOND KINETICS IN HEALTH AND DISEASE (Federal Gov)
Jul 1 2010 - Apr 30 2015
MULTISCALE MODEL OF PLATELET ADHESION AND THROMBUS FORMATION (Federal Gov)
Mar 8 2010 - Dec 31 2014
EVALUATING NEONATAL PLATELET FUNCTION AND RESPONSE TO ANTITHROMBOTIC AGENTS (Private)
Jul 1 2013 - Jun 30 2014
CLASS I PI3K INHIBITORS AS ADJUNCTIVE THERAPY FOR LEUKEMIA (Private)
Jul 1 2012 - Jun 30 2014
SPONSORED RESEARCH AGREEMENT WITH GILEAD (Private)
Jun 26 2012 - Jun 25 2014
TARGETING CLASS I PI3KS IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (Federal Gov)
Aug 1 2010 - Aug 31 2013
CLASS I P13KS AS A THERAPEUTIC TARGET IN ACUTE LYMPHOBLASTIC LEUKEMIA (Private)
Oct 1 2009 - Sep 30 2012
EPIC (R) IMAGING LABEL FREE DETECTION PROTOTYPE SYSTEM EVALU ATION AGREEMENT (Private)
Mar 17 2011 - Mar 16 2012
SPONSOREDRESEARCH AGREEMENT WITH CALISTOGA PHARMACEUTICALS, INC. (Private)
Mar 15 2011 - Mar 14 2012
A NOVEL ANIMAL MODEL FOR THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP) (Private)
Jan 1 2010 - Dec 31 2011
A NOVEL BIOLOGICAL PLATFORM FOR DEVELOPMENT AND TESTING OF A NTITHROMBOTIC DRUGS AND TARGETED NON-INV (NY State Gov)
Mar 1 2008 - Oct 31 2011
P13KDELTA MODULATION OF NEUTROPHIL TRAFFICKING (Federal Gov)
Jul 1 2005 - Jul 31 2010
METHODS IN MOLECULAR IMAGING AND TARGETED THERAPEUTICS (Federal Gov)
Jul 1 2005 - Jun 30 2009
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF THE VWF-A1 DOMAIN (Federal Gov)
May 1 2000 - Apr 30 2009
For a complete list of publications, please visit PubMed.gov